These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37857829)

  • 1. Acamprosate reduces ethanol intake in the rat by a combined action of different drug components.
    Ademar K; Loftén A; Nilsson M; Domi A; Adermark L; Söderpalm B; Ericson M
    Sci Rep; 2023 Oct; 13(1):17863. PubMed ID: 37857829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium acamprosate and calcium exert additive effects on nucleus accumbens dopamine in the rat.
    Ademar K; Adermark L; Söderpalm B; Ericson M
    Addict Biol; 2022 Sep; 27(5):e13224. PubMed ID: 36001425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The glycine reuptake inhibitor Org24598 and acamprosate reduce ethanol intake in the rat; tolerance development to acamprosate but not to Org24598.
    Lidö HH; Marston H; Ericson M; Söderpalm B
    Addict Biol; 2012 Sep; 17(5):897-907. PubMed ID: 21955180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acamprosate's ethanol intake-reducing effect is associated with its ability to increase dopamine.
    Chau P; Lidö HH; Söderpalm B; Ericson M
    Pharmacol Biochem Behav; 2018 Dec; 175():101-107. PubMed ID: 30266455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycine receptors involved in acamprosate's modulation of accumbal dopamine levels: an in vivo microdialysis study.
    Chau P; Stomberg R; Fagerberg A; Söderpalm B; Ericson M
    Alcohol Clin Exp Res; 2010 Jan; 34(1):32-8. PubMed ID: 19860810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycine receptors in the nucleus accumbens involved in the ethanol intake-reducing effect of acamprosate.
    Chau P; Höifödt-Lidö H; Löf E; Söderpalm B; Ericson M
    Alcohol Clin Exp Res; 2010 Jan; 34(1):39-45. PubMed ID: 19860809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of acute acamprosate and homotaurine on ethanol intake and ethanol-stimulated mesolimbic dopamine release.
    Olive MF; Nannini MA; Ou CJ; Koenig HN; Hodge CW
    Eur J Pharmacol; 2002 Feb; 437(1-2):55-61. PubMed ID: 11864639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acamprosate produces its anti-relapse effects via calcium.
    Spanagel R; Vengeliene V; Jandeleit B; Fischer WN; Grindstaff K; Zhang X; Gallop MA; Krstew EV; Lawrence AJ; Kiefer F
    Neuropsychopharmacology; 2014 Mar; 39(4):783-91. PubMed ID: 24081303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of acamprosate on prefrontal cortical function are mimicked by CaCl2 and they are influenced by the history of alcohol exposure.
    Melugin PR; Wu F; Munoz C; Phensy A; Pradhan G; Luo Y; Nofal A; Manepalli R; Kroener S
    Neuropharmacology; 2022 Jul; 212():109062. PubMed ID: 35430241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mGluR5 antagonist MPEP elevates accumbal dopamine and glycine levels; interaction with strychnine-sensitive glycine receptors.
    Chau P; Söderpalm B; Ericson M
    Addict Biol; 2011 Oct; 16(4):591-9. PubMed ID: 21790901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A homotaurine derivative reduces the voluntary intake of ethanol by rats: are cerebral GABA receptors involved?
    Boismare F; Daoust M; Moore N; Saligaut C; Lhuintre JP; Chretien P; Durlach J
    Pharmacol Biochem Behav; 1984 Nov; 21(5):787-9. PubMed ID: 6096898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acamprosate {monocalcium bis(3-acetamidopropane-1-sulfonate)} reduces ethanol-drinking behavior in rats and glutamate-induced toxicity in ethanol-exposed primary rat cortical neuronal cultures.
    Oka M; Hirouchi M; Tamura M; Sugahara S; Oyama T
    Eur J Pharmacol; 2013 Oct; 718(1-3):323-31. PubMed ID: 24012782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The acute anti-craving effect of acamprosate in alcohol-preferring rats is associated with modulation of the mesolimbic dopamine system.
    Cowen MS; Adams C; Kraehenbuehl T; Vengeliene V; Lawrence AJ
    Addict Biol; 2005 Sep; 10(3):233-42. PubMed ID: 16109584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The GlyT1-inhibitor Org 24598 facilitates the alcohol deprivation abolishing and dopamine elevating effects of bupropion + varenicline in rats.
    Olsson Y; Lidö H; Ademar K; Cadeddu D; Ericson M; Söderpalm B
    J Neural Transm (Vienna); 2024 Jan; 131(1):95-106. PubMed ID: 37773223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium chloride mimics the effects of acamprosate on cognitive deficits in chronic alcohol-exposed mice.
    Pradhan G; Melugin PR; Wu F; Fang HM; Weber R; Kroener S
    Psychopharmacology (Berl); 2018 Jul; 235(7):2027-2040. PubMed ID: 29679288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rising taurine and ethanol concentrations in nucleus accumbens interact to produce the dopamine-activating effects of alcohol.
    Ericson M; Chau P; Adermark L; Söderpalm B
    Adv Exp Med Biol; 2013; 775():215-23. PubMed ID: 23392937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anti-craving drug acamprosate reduces c-fos expression in rats undergoing ethanol withdrawal.
    Putzke J; Spanagel R; Tölle TR; Zieglgänsberger W
    Eur J Pharmacol; 1996 Dec; 317(1):39-48. PubMed ID: 8982717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic acamprosate eliminates the alcohol deprivation effect while having limited effects on baseline responding for ethanol in rats.
    Heyser CJ; Schulteis G; Durbin P; Koob GF
    Neuropsychopharmacology; 1998 Feb; 18(2):125-33. PubMed ID: 9430136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acamprosate and alcohol: III. Effects on alcohol discrimination in the rat.
    Spanagel R; Zieglgänsberger W; Hundt W
    Eur J Pharmacol; 1996 Jun; 305(1-3):51-6. PubMed ID: 8813531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local acamprosate modulates dopamine release in the rat nucleus accumbens through NMDA receptors: an in vivo microdialysis study.
    Cano-Cebrián MJ; Zornoza-Sabina T; Guerri C; Polache A; Granero L
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Feb; 367(2):119-25. PubMed ID: 12595952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.